Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 1377748)

Published in Am J Hum Genet on February 01, 1999

Authors

R Gryfe1, N Di Nicola, G Lal, S Gallinger, M Redston

Author Affiliations

1: Centre for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada M5G 1X5.

Articles citing this

Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16

Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A (2004) 3.62

Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am J Hum Genet (2000) 1.21

Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim. Am J Hum Genet (2003) 1.16

A DNA polymerase epsilon mutant that specifically causes +1 frameshift mutations within homonucleotide runs in yeast. Genetics (2000) 1.05

Accurate typing of short tandem repeats from genome-wide sequencing data and its applications. Genome Res (2015) 0.96

A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening. J Med Genet (1999) 0.90

Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg (2005) 0.86

Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis. World J Surg (2005) 0.85

Microsatellite interruptions stabilize primate genomes and exist as population-specific single nucleotide polymorphisms within individual human genomes. PLoS Genet (2014) 0.82

Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer (2001) 0.82

Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer (2001) 0.80

Genetic factors and colorectal cancer in Ashkenazi Jews. Fam Cancer (2004) 0.80

A single nucleotide primer extension assay to detect the APC I1307K gene variant. J Mol Diagn (2003) 0.80

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer. Br J Cancer (1999) 0.80

Inherited colorectal cancer syndromes. Clin Colon Rectal Surg (2009) 0.79

Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group. Genet Med (2001) 0.78

Familial adenomatous polyposis and extracolonic cancer. Dig Dis Sci (2001) 0.77

Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk. Mol Carcinog (2013) 0.76

miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli. World J Surg Oncol (2016) 0.75

Gastrointestinal tract cancers: Genetics, heritability and germ line mutations. Oncol Lett (2017) 0.75

Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects. Fam Cancer (2016) 0.75

Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers. Dig Dis Sci (2003) 0.75

Colonic Adenomas Do Not Cosegregate with the I1307K APC Missense Mutation in an Israeli Non-Ashkenazi Family. Dig Dis Sci (2005) 0.75

Articles cited by this

Lessons from hereditary colorectal cancer. Cell (1996) 25.73

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96

Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med (1998) 8.47

Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

Informed consent for genetic research on stored tissue samples. JAMA (1995) 5.54

Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet (1996) 4.36

Alleles of the APC gene: an attenuated form of familial polyposis. Cell (1993) 3.84

Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet (1996) 2.82

The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32

The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A (1998) 2.27

Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med (1996) 2.14

Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res (1998) 1.79

Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet (1996) 1.67

Missense mutations in disease genes: a Bayesian approach to evaluate causality. Am J Hum Genet (1998) 1.62

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55

The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res (1997) 1.12

Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews. Genet Epidemiol (1992) 0.94

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res (1998) 0.88

Articles by these authors

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med (2000) 8.68

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95

MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet (1995) 2.49

Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet (1998) 2.12

Allelotype of pancreatic adenocarcinoma. Cancer Res (1994) 2.11

Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol (1999) 2.02

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93

Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85

Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res (1994) 1.85

Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum (1996) 1.82

Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res (2000) 1.81

Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res (1998) 1.79

Molecular biology of colorectal cancer. Curr Probl Cancer (1998) 1.70

Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69

Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. J Natl Cancer Inst (2001) 1.67

Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res (1999) 1.62

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res (2000) 1.57

Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res (2000) 1.56

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55

Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can (2000) 1.55

Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51

Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics. Cancer Invest (1993) 1.42

Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology (1994) 1.41

MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res (1996) 1.41

Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (2007) 1.39

Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36

Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35

Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res (1996) 1.34

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32

Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl (2000) 1.32

Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29

Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet (1995) 1.29

Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet (2007) 1.25

The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut (2010) 1.23

Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet (2001) 1.20

Risk factors in elective laparoscopic cholecystectomy for conversion to open cholecystectomy. J Am Coll Surg (1994) 1.18

A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A (1993) 1.17

Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology (1985) 1.16

STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin Genet (1999) 1.13

Microsatellite instability, mismatch repair deficiency, and colorectal cancer. Surgery (2001) 1.13

Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol (1994) 1.13

A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11

Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet (1999) 1.10

Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10

Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene (2001) 1.10

The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet (1996) 1.07

Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol (1992) 1.06

Analysis of mRNA from microdissected frozen tissue sections without RNA isolation. Am J Pathol (1998) 1.05

Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut (2005) 1.03

Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. J Clin Pathol (2005) 1.02

Familial adenomatous polyposis. Semin Surg Oncol (2000) 0.99

The APCI1307K allele and breast cancer risk. Nat Genet (1998) 0.99

Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology (1987) 0.99

Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol) (2006) 0.98

K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis (1993) 0.98

Natural history of aberrant crypt foci. A surgical approach. Dis Colon Rectum (1996) 0.98

Essays on science and society. Defining disease in the genomics era. Science (2001) 0.98

Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology (2001) 0.97

Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD). Breast Cancer Res Treat (1997) 0.97

Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Cancer Res (2001) 0.97

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer (2000) 0.97

ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis. Clin Genet (2007) 0.96

Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. Int J Cancer (1998) 0.96

Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis. Dis Colon Rectum (2001) 0.96

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. Infect Immun (2005) 0.95

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Ther (1999) 0.95

p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival. Mol Pathol (1998) 0.94

Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology (2008) 0.94

Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol (1993) 0.94

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer (2011) 0.93

Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res (1998) 0.92

APC mutation and the crypt cycle in murine and human intestine. Am J Pathol (1997) 0.92

Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients. Br J Cancer (2011) 0.92

CDH1/E-cadherin germline mutations in early-onset gastric cancer. J Med Genet (2006) 0.92

Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet (1993) 0.92

Early laparoscopic cholecystectomy for acute cholecystitis: a safe procedure. J Gastrointest Surg (2000) 0.91

A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation (1995) 0.91

In situ hypothermic liver preservation during radical liver resection with major vascular reconstruction. Br J Surg (2009) 0.90

Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res (1997) 0.90

A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening. J Med Genet (1999) 0.90

Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones. Gut (1986) 0.89